MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.50
-0.85 (-6.88%)
At close: Dec 5, 2025, 4:00 PM EST
11.73
+0.23 (2.00%)
After-hours: Dec 5, 2025, 5:50 PM EST
MiNK Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 54 | 28 | 37 | 88 | 149 | - | |
| Market Cap Growth | 96.39% | -25.23% | -58.11% | -40.99% | - | - | |
| Enterprise Value | 45 | 26 | 31 | 64 | 214 | - | |
| Last Close Price | 11.50 | 6.97 | 10.70 | 26.10 | 44.60 | - | |
| PB Ratio | - | -1.41 | -2.05 | -219.74 | 6.29 | - | |
| P/TBV Ratio | - | - | - | - | 6.29 | - | |
| Debt / Equity Ratio | -0.42 | -0.25 | - | - | - | -0.81 | |
| Quick Ratio | 1.06 | 0.66 | 0.30 | 1.55 | 2.36 | 0.21 | |
| Current Ratio | 1.08 | 0.72 | 0.32 | 1.61 | 2.41 | 0.29 | |
| Return on Equity (ROE) | - | - | - | -239.50% | - | - | |
| Return on Assets (ROA) | -69.61% | -137.35% | -110.10% | -62.69% | -51.92% | -230.14% | |
| Return on Capital (ROIC) | - | - | - | -165.50% | -169.44% | - | |
| Return on Capital Employed (ROCE) | -813.00% | 911.20% | 334.60% | -352.20% | -78.30% | 111.70% | |
| Earnings Yield | -22.89% | -39.05% | -60.80% | -31.74% | -20.22% | - | |
| FCF Yield | -10.33% | -34.60% | -42.87% | -21.68% | -8.75% | - | |
| Buyback Yield / Dilution | -12.09% | -9.82% | -2.04% | -29.38% | -7.95% | -0.21% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.